Latest Articles

Publication Date
Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer - Frontiers

Single-cell sequencing reveals the role of aggrephagy-related patterns in tumor microenvironment, prognosis and immunotherapy in endometrial cancer Frontiers

Published: March 4, 2025, 1:24 p.m.
Can immuno-oncology revolutionize endometrial cancer treatment in Korea? - KBR

Can immuno-oncology revolutionize endometrial cancer treatment in Korea? KBR

Published: March 4, 2025, 7:13 a.m.
Doctor develops non-invasive test for endometrial cancer - KJZZ

Doctor develops non-invasive test for endometrial cancer KJZZ

Published: March 3, 2025, noon
Arizona doctor develops non-invasive test for endometrial cancer - KJZZ

Arizona doctor develops non-invasive test for endometrial cancer KJZZ

Published: March 3, 2025, noon
The potential impact of RNA splicing abnormalities on immune regulation in endometrial cancer - Nature.com

The potential impact of RNA splicing abnormalities on immune regulation in endometrial cancer Nature.com

Published: March 3, 2025, 11:33 a.m.
Tumor Volume Index as a Predictor of Pelvic Lymph Node Metastasis in Low-Risk Endometrial Cancer - Cureus

Tumor Volume Index as a Predictor of Pelvic Lymph Node Metastasis in Low-Risk Endometrial Cancer Cureus

Published: Feb. 28, 2025, 6:36 p.m.
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - BioMed Central

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis BioMed Central

Published: Feb. 28, 2025, 10:47 a.m.
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - bmcwomenshealth.biomedcentral.com

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis bmcwomenshealth.biomedcentral.com

Published: Feb. 28, 2025, 10:47 a.m.
Deciphering the Role of Circulating miRNAs in the Etiology and Pathophysiology of Endometriosis: An Updated Compiled Review.

Endometriosis is characterized by the presence of endometrial tissue outside of the uterus. It is a benign chronic condition with incapacitating symptoms like infertility and pelvic pain. Endometriosis has a …

Published: Feb. 25, 2025, midnight
Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation - ACS Publications

Predictive Significance of Glycosyltransferase-Related lncRNAs in Endometrial Cancer: A Comprehensive Analysis and Experimental Validation ACS Publications

Published: Feb. 24, 2025, 11:12 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!